Evaluasi Kualitatif dan Kuantitatif Antibiotik pada Pasien DM Tipe Dua dengan Luka Gangren di Rumah Sakit Gunung Jati Cirebon
DOI:
https://doi.org/10.70608/5fcam458Keywords:
Audit kualitatif alur Gyssens, Audit kuantitatif DDD, Diabetes tipe dua, ulkus gangreneAbstract
Diabetes melitus merupakan penyakit yang sering di jumpai di masyarakat khususnya pada orang tua yang memiliki usia lanjut, diabetes mellitus merupakn penyakit yang di sebabkan oleh gangguan metabolisme tubuh antara lain karbohidrat protein dan lemak tipe diabetes mellitus terbagi menjadi dua jenis, yaitu tipe satu dan tipe dua, penelitian ini bertujuan untuk mengkaji pola pemberian antibiotik secara kualitatif dan kuantitatif pada pasien ulkus diabetik tipe dua yang terdapat luka ulkus dan gangren di rumah sakit Gunung Jati Cirebon. Hasil dari penelitian ini di harapkan mampu memberikan dampak positif pada bidang ilmu pengetahuan mengenai gambaran penggunan antibiotik pada pasien yang mengidap diabetes melitus yang mempunyai luka ulkus diabetik dan gangren. Penelitian ini termasuk penelitian noneksperimental dengan metode rendem sampling. Hasil dari penelitian ini menggambarkan bahwa konsumsi antibiotik pada RSUD Gunung Jati kota Cirebon menunjukan pemakaian yang cukup tinggi yakni sebesar (68,9 DDD / 100 hari rawat), hasil ini sudah tergolong cukup baik, dari pengujian allur Gyssens di peroleh 11 kriteria (IIB), 1 kriteria (IVA), (IV) dan (IVB), serta 16 pasien masuk dalam kriteria (IVD).
Downloads
References
[1] L. E. Purwanti and S. Maghfirah, “Faktor risiko komplikasi kronis (kaki diabetik) dalam diabetes mellitus tipe 2,” Indones. J. Heal. Sci., vol. 7, no. 1, 2016.
[2] R. Rachmantoko, Z. Afif, D. Rahmawati, R. Rakhmatiar, and S. N. Kurniawan, “Diabetic neuropathic pain,” J. Pain, Headache Vertigo, vol. 2, no. 1, pp. 8–12, 2021, doi: 10.21776/ub.jphv.2021.002.01.3. DOI: https://doi.org/10.21776/ub.jphv.2021.002.01.3
[3] B. Keperawatan Akper, T. Kotamobagu, J. Kesatria, M. ) Kota, and K. Abstrak, “Article info :Sending on,” Jurnal Keperawatan Respati Yogyakarta, vol. 5, no. 3, pp. 479–485, 2018, [Online]. Available: http://nursingjurnal.respati.ac.id/index.php/JKRY/index
[4] J. Ilmiah Kesehatan Sandi Husada, A. Utia Detty, N. Fitriyani, T. Prasetya, and B. Florentina, “Karakteristik Ulkus Diabetikum Pada Penderita Diabetes Melitus The Characteristics of Diabetic Ulcer in Patients with Diabetes Mellitus,” akper sandikarsa.e-journal.id, vol. 11, no. 1, pp. 258–264, 2020, doi: 10.35816/jiskh.v10i2.261. DOI: https://doi.org/10.35816/jiskh.v11i1.261
[5] L. P. F. Abbade et al., “Consensus on the diagnosis and management of chronic leg ulcers - Brazilian Society of Dermatology,” An Bras Dermatol, vol. 95, pp. 1–18, Nov. 2020, doi: 10.1016/j.abd.2020.06.002. DOI: https://doi.org/10.1016/j.abd.2020.06.002
[6] R. Silaban, P. Lestari, M. Daryeti, and D. Merdekawati, “Ankle Brachial Indeks (ABI), Kadar Glukosa Darah dan Nutrisi Pada Ulkus Diabetikum,” Jurnal Endurance, vol. 4, no. 3, p. 449, Oct. 2019, doi: 10.22216/jen.v4i3.4560. DOI: https://doi.org/10.22216/jen.v4i3.4560
[7] C. Pouget, C. Dunyach-Remy, A. Pantel, S. Schuldiner, A. Sotto, and J. P. Lavigne, “Biofilms in diabetic foot ulcers: Significance and clinical relevance,” Oct. 01, 2020, MDPI AG. doi: 10.3390/microorganisms8101580. DOI: https://doi.org/10.3390/microorganisms8101580
[8] R. Johnson, A. Osbourne, J. Rispoli, and C. Verdin, “The Diabetic Foot Assessment,” Orthopaedic Nursing, vol. 37, no. 1, pp. 13–21, 2018, doi: 10.1097/NOR.0000000000000414. DOI: https://doi.org/10.1097/NOR.0000000000000414
[9] M. H. Basri, “Pengalaman Pasien DM TIPE 2 dalam Melakukan Perawatan Ulkusdiabetik Secara Mandiri,” Jurnal Endurance, vol. 4, no. 1, p. 58, Mar. 2019, doi: 10.22216/jen.v4i1.3066. DOI: https://doi.org/10.22216/jen.v4i1.3066
[10] Y. Farida and dan I. Claudia Putri, “Efek Penggunaan Simvastatin Terhadap Kenaikan Gula Darah Puasa Pasien Diabetes Melitus Tipe 2,” 2016.
[11] M. Rahmawati, V. Maulidya, and A. M. Ramadhan, “Kajian Kesesuaian Pemilihan Antibiotik Empiris pada Pasien Ulkus Diabetikum Di Instalasi Rawat Inap Rumah Sakit Abdul Wahab Sjahranie Samarinda,” Proceeding of Mulawarman Pharmaceuticals Conferences, vol. 8, pp. 119–127, Dec. 2018, doi: 10.25026/mpc.v8i1.313. DOI: https://doi.org/10.25026/mpc.v8i1.313
[12] E. W. Gregg, “The changing tides of the type 2 diabetes epidemic—smooth sailing or troubled waters ahead? Kelly West Award Lecture 2016,” Diabetes Care, vol. 40, no. 10, pp. 1289–1297, 2017, doi: 10.2337/dci16-0055. DOI: https://doi.org/10.2337/dci16-0055
[13] K. Ogurtsova et al., “IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040,” Diabetes Res. Clin. Pract., vol. 128, pp. 40–50, 2017, doi: 10.1016/j.diabres.2017.03.024. DOI: https://doi.org/10.1016/j.diabres.2017.03.024
[14] Inzucchi SE., Bergenstal RM., Buse JB., et al.,,. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient- Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140-149. DOI: https://doi.org/10.2337/dc14-2441
[15] M. J. Davies et al., “Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD),” Diabetologia, vol. 61, pp. 2461–2498, 2018, doi: 10.1007/s00125-018-4729-5. DOI: https://doi.org/10.1007/s00125-018-4729-5
[16] A. D. Association, “Standards of medical care in diabetes—2018 abridged for primary care providers,” Clin. diabetes a Publ. Am. Diabetes Assoc., vol. 36, no. 1, p. 14, 2018, doi: 10.2337/cd17-0119. DOI: https://doi.org/10.2337/cd17-0119
[17] A. A. Al Hayek, A. A. Robert, A. Al Saeed, A. A. Alzaid, and F. S. Al Sabaan, “Factors associated with health-related quality of life among Saudi patients with type 2 diabetes mellitus: a cross-sectional survey,” Diabetes Metab. J., vol. 38, no. 3, p. 220, 2014, doi: 10.4093/dmj.2014.38.3.220. DOI: https://doi.org/10.4093/dmj.2014.38.3.220
[18] D. A. Perwitasari, W. Adikusuma, S. Rikifani, W. Supadmi, and A. A. Kaptein, “Quality of Life and Adherence of Diabetic Patients in Different Treatment Regimens,” Indones. J. Clin. Pharm., vol. 3, no. 4, pp. 107–113, 2014, doi: 10.15416/ijcp.2014.3.4.107. DOI: https://doi.org/10.15416/ijcp.2014.3.4.107
[19] A. N. Goudswaard and D. M. Kendall, "Review: Insulin monotherapy and insulin combined with oral hypoglycemic agents provide similar glycemic control/COMMENTARY," ACP J. Club, vol. 142, (3), pp. 62, 2005. Available: https://www.proquest.com/scholarly-journals/review-insulin-monotherapy-combined-with-oral/docview/198641680/se-2. DOI: https://doi.org/10.7326/ACPJC-2005-142-3-062
[20] J. Pais-ribeiro and P. Freitas, “Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital,” Diabetes, Metab. Syndr. Obes. Targets Ther., pp. 219–226, 2015, doi: 10.2147/DMSO.S80472. DOI: https://doi.org/10.2147/DMSO.S80472
[21] M. Fatima, S. Sadeeqa, and S. U. R. Nazir, “Metformin and its gastrointestinal problems: A review,” Biomed Res, vol. 29, no. 11, pp. 2285–2289, 2018. DOI: https://doi.org/10.4066/biomedicalresearch.40-18-526
[22] X. Gao, X. Cai, W. Yang, Y. Chen, X. Han, and L. Ji, “Meta‐analysis and critical review on the efficacy and safety of alpha‐glucosidase inhibitors in Asian and non‐Asian populations,” J. Diabetes Investig., vol. 9, no. 2, pp. 321–331, 2018, doi: 10.1111/jdi.12711. DOI: https://doi.org/10.1111/jdi.12711
[23] F. Akinci, A. Yildirim, H. Gözü, H. Sargın, E. Orbay, and M. Sargın, “Assessment of health-related quality of life (HRQoL) of patients with type 2 diabetes in Turkey,” Diabetes Res. Clin. Pract., vol. 79, no. 1, pp. 117–123, 2008, doi: 10.1016/j.diabres.2007.07.003. DOI: https://doi.org/10.1016/j.diabres.2007.07.003
[24] M. Chappidi, S. Shivananjiah, C. Thirthahalli, R. Kunnavil, and M. Chappidi, “Complications of diabetes mellitus among patients attending the out-patient department of a tertiary care hospital,” Int J Community Med Public Heal, vol. 5, no. 1, pp. 341–348, 2018, doi: 10.18203/2394-6040.ijcmph20175810. DOI: https://doi.org/10.18203/2394-6040.ijcmph20175810
[25] Z. Liu, C. Fu, W. Wang, and B. Xu, “Prevalence of chronic complications of type 2 diabetes mellitus in outpatients-a cross-sectional hospital based survey in urban China,” Health Qual. Life Outcomes, vol. 8, pp. 1–9, 2010, doi: 10.1186/1477-7525-8-62 DOI: https://doi.org/10.1186/1477-7525-8-62
[26] B. Bin Younis, R. Arshad, H. Yousuf, F. Salman, J. Masood, and S. Khurshid, “Impact of type 2 diabetes mellitus on quality of life in people with diabetespresenting to a specialist diabetes clinic,” Turkish J. Med. Sci., vol. 47, no. 1, pp. 123–126, 2017, doi: 10.3906/sag-1508-3. DOI: https://doi.org/10.3906/sag-1508-3
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Gugun Gumelar, Rizky Budi Santoso, M. Taufik Hidayat, Ahmad Qoyyim, Danang Prastyaning Amukti (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
